Bacharier L B, Boner A, Carlsen K-H, Eigenmann P A, Frischer T, Götz M, Helms P J, Hunt J, Liu A, Papadopoulos N, Platts-Mills T, Pohunek P, Simons F E R, Valovirta E, Wahn U, Wildhaber J
Department of Pediatrics, Washington University, St Louis, MO, USA.
Allergy. 2008 Jan;63(1):5-34. doi: 10.1111/j.1398-9995.2007.01586.x.
Asthma is the leading chronic disease among children in most industrialized countries. However, the evidence base on specific aspects of pediatric asthma, including therapeutic strategies, is limited and no recent international guidelines have focused exclusively on pediatric asthma. As a result, the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology nominated expert teams to find a consensus to serve as a guideline for clinical practice in Europe as well as in North America. This consensus report recommends strategies that include pharmacological treatment, allergen and trigger avoidance and asthma education. The report is part of the PRACTALL initiative, which is endorsed by both academies.
在大多数工业化国家,哮喘是儿童中最主要的慢性疾病。然而,关于儿童哮喘特定方面(包括治疗策略)的证据基础有限,并且最近没有专门针对儿童哮喘的国际指南。因此,欧洲变态反应与临床免疫学会和美国变态反应、哮喘与免疫学会指定了专家团队来达成共识,以作为欧洲和北美的临床实践指南。这份共识报告推荐了包括药物治疗、避免接触过敏原和触发因素以及哮喘教育在内的策略。该报告是PRACTALL倡议的一部分,该倡议得到了两个学会的认可。